Fundraising Fox
EndoSound
Portland, US · Founded 2020 · Delaware corporation · 1 known investors
Find your way into EndoSound
Sign up to see every warm intro you have to EndoSound
- Paths you didn't know you had: your email and LinkedIn already hold routes to the EndoSound team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
EndoSound makes the EndoSound Vision System (EVS), a technology that converts standard upper GI endoscopes into a functioning endoscopic ultrasound (EUS) scope at lower cost than traditional systems. It targets ambulatory surgery centers and other facilities that cannot afford or justify conventional EUS equipment.
Founders & leadership
EndoSound was founded in 2020 by Scott Corbett and Stephen Steinberg.
SC
Scott CorbettCo-founder · Chief Technology OfficerFounder and CTO of EndoSound, Scott Corbett has spent four decades in biomedical engineering, including senior leadership roles at multiple startup ventures in the Pacific Northwest. His background encompasses acoustics, medical ultrasound, sensors, and mechanical/electrical packaging, with over 20 patents in medical devices and related technologies.
SS
Stephen SteinbergFounder & Chief Medical Officer
SA
Scott Aldrich, Jr.Chief Executive OfficerScott Aldrich, Jr. is Chief Executive Officer of EndoSound, which converts standard endoscopes into endoscopic ultrasound systems. He has held commercial and operational leadership roles in medical device companies, with experience in marketing, sales, operations, and strategy across US and international markets.
JC
Josh CohnChief Commercial OfficerJosh Cohn is Chief Commercial Officer at EndoSound, which develops technology that upgrades standard endoscopes into endoscopic ultrasound systems for use in ambulatory surgical settings. He brings two decades of experience in medical device sales, business development, and strategic planning.
PH
Paul HenwoodChief Operations Officer
Board
MS
Morris SandlerBoard director
BT
Brian TinkhamBoard director
NP
Nicholas PuroBoard director
WR
William RhodesBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$5M disclosed across 5 rounds · 2021–2026
▶$250KraisedJun 2026 · 1 investors · Other Health CareRule 506(b)
▶$250KraisedJun 2026 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Scott AldrichExecutive Officer
- Scott CorbettExecutive Officer, Director
- Nicholas PuroDirector
- Stephen SteinbergExecutive Officer, Director
- Morris SandlerDirector
- Offering amount
- $5M
- Amount sold
- $250K
- Minimum investment
- $25K
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.9MraisedAug 2025 · 10 investors · Other Health CareRule 506(c)
▶$1.9MraisedAug 2025 · 10 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- Scott CorbettExecutive Officer, Director
- Brian TinkhamDirector
- Nicholas PuroDirector
- William RhodesDirector
- Morris SandlerDirector
- Stephen SteinbergExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $1.9M
- Minimum investment
- $50K
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06c
▶$2.4MraisedMay 2023 · 17 investors · Other Health CareRule 506(b)
▶$2.4MraisedMay 2023 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Nicholas PuroDirector
- Morris SandlerDirector
- Stephen SteinbergExecutive Officer, Director
- William RhodesDirector
- Brian TinkhamDirector
- Scott CorbettExecutive Officer, Director
- Offering amount
- $5.4M
- Amount sold
- $2.4M
- Minimum investment
- $10K
- First sale
- Apr 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$50KraisedMar 2022 · 1 investors · Other Health CareRule 506(b)
▶$50KraisedMar 2022 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Scott CorbettExecutive Officer, Director, Promoter
- Stephen SteinbergExecutive Officer, Director, Promoter
- Morris SandlerDirector
- Offering amount
- $1.5M
- Amount sold
- $50K
- Minimum investment
- $10K
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$360.8KraisedMar 2021 · 4 investors · Other Health CareRule 506(b)
▶$360.8KraisedMar 2021 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Stephen SteinbergExecutive Officer, Director, Promoter
- Scott CorbettExecutive Officer, Director, Promoter
- Offering amount
- $2M
- Amount sold
- $360.8K
- Minimum investment
- $10K
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 6
OlympusamericaOlympus develops medical technologies and solutions for detecting and treating disease. The company serves healthcare systems, patients, and medical professionals globally.
MD Anderson Cancer CenterUT MD Anderson is a cancer research and treatment center that provides patient care, conducts research, and offers education in cancer prevention and treatment. It is part of the University of Texas System and operates as a nonprofit medical institution.
FujifilmFujifilm is a diversified manufacturer operating across healthcare (prevention, diagnosis, and treatment), electronics, business innovation, and imaging, producing products and services including film, photography, medical technology, and digital transformation solutions. It serves consumers and business customers globally across these fields.
Boston ScientificBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
CancerresearchukCancer Research UK funds research across discovery, detection, prevention and treatment of cancer to improve patient outcomes and extend survival. It operates as a research funder and scientific organization serving academic and clinical researchers.
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Companies working in the same space as EndoSound.
In the news
EndoSound has filed a notice of an exempt offering of securities to raise $5 Million in New Funding. - intelligence360intelligence360.news · Jul 2026Frequently asked questions
- What does EndoSound do?
- EndoSound makes the EndoSound Vision System (EVS), a technology that converts standard upper GI endoscopes into a functioning endoscopic ultrasound (EUS) scope at lower cost than traditional systems. It targets ambulatory surgery centers and other facilities that cannot afford or justify conventional EUS equipment.
- Who founded EndoSound?
- EndoSound was founded by Scott Corbett, Stephen Steinberg in 2020.
- Who are EndoSound's investors?
- EndoSound's investors include D3VC.
- How much funding has EndoSound raised?
- EndoSound has disclosed $5M raised across 5 rounds.
- Where is EndoSound headquartered?
- EndoSound is headquartered in Portland, US.